Aromasin Meds for Breast Cancer Pictures

Links shared publicly online about this topic

Aromasin Reduced Breast Cancer Risk in Postmenopausal Women - Drugs.com MedNews

drugs.com — “The anti-estrogen drug Aromasin appears to cut the odds of breast cancer by 65 percent in high-risk postmenopausal women, new research has found. And unlike othView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on June 6, 2011 at 1:32 am By:

drugscom Drugs.com Health Site

Aromasin Reduced Breast Cancer Risk in Postmenopausal Women - http://bit.ly/j8vbsn

12 months ago...

Aromasin Reduced Breast Cancer Risk in Postmenopausal Women - Drugs.com MedNews

drugs.com — “The anti-estrogen drug Aromasin appears to cut the odds of breast cancer by 65 percent in high-risk postmenopausal women, new research has found. And unlike othView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on June 4, 2011 at 7:05 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Aromasin Reduced Breast Cancer Risk in Postmenopausal Women: SATURDAY, June 4 -- The anti-estrogen drug Ar... http://bit.ly/je4qVi #drug

12 months ago...

Medical News: SABCS: Mixed Picture for Neoadjuvant Breast CA Tx - in Meeting Coverage, SABCS from MedPage Today

medpagetoday.com — “SAN ANTONIO -- Neoadjuvant trials reported here at the San Antonio Breast Cancer Symposium gave two thumbs up to anti-HER2 combos but flunked bevacizumab (Avastin), as a leading oncologist explains inView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on December 13, 2010 at 4:09 pm By:

MedicalNews Medical News Health News

SABCS: Mixed Picture for Neoadjuvant Breast CA Tx (with video) http://bit.ly/evxZwR

1 year ago...

Medical News: SABCS: Mixed Picture for Neoadjuvant Breast CA Tx - in Meeting Coverage, SABCS from MedPage Today

medpagetoday.com — “SAN ANTONIO -- Neoadjuvant trials reported here at the San Antonio Breast Cancer Symposium gave two thumbs up to anti-HER2 combos but flunked bevacizumab (Avastin), as a leading oncologist explains inView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on December 13, 2010 at 4:53 pm By:

FightCancer FightCancer Health News

SABCS: Mixed Picture for Neoadjuvant Breast CA Tx (with video) http://bit.ly/gqkI3U

1 year ago...

SABCS: Mixed Picture for Neoadjuvant Breast CA Tx (with video) - QualityPoint Technologies

qualitypointtech.net — “SAN ANTONIO (MedPage Today) -- Neoadjuvant trials reported here at the San Antonio Breast Cancer Symposium gave two thumbs up to anti-HER2 combos but flunked bevacizumab (Avastin), as a leading oncologist explains in this exclusive InFocus report.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on December 13, 2010 at 5:03 pm By:

MedicalFeed MedicalFeed Health News Feed

SABCS: Mixed Picture for Neoadjuvant Breast CA Tx (with video): SAN ANTONIO (MedPage Today) -- Neoadjuvant trials ... http://bit.ly/hIGoBT

1 year ago...

Medical News: ASCO: Exemestane Scores for Primary Prevention of Breast CA - in Meeting Coverage, ASCO from MedPage Today

medpagetoday.com — “CHICAGO -- Make room, tamoxifen: The aromatase inhibitor exemestane (Aromasin) prevents first breast cancers in moderate- to high-risk postmenopausal women, according to randomized trial results.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on June 4, 2011 at 4:19 pm By:

FightCancer FightCancer Health News

ASCO: Exemestane Scores for Primary Prevention of Breast CA (CME/CE) http://bit.ly/lVq0E0

12 months ago...

Medical News: ASCO: Exemestane Scores for Primary Prevention of Breast CA - in Meeting Coverage, ASCO from MedPage Today

medpagetoday.com — “CHICAGO -- Make room, tamoxifen: The aromatase inhibitor exemestane (Aromasin) prevents first breast cancers in moderate- to high-risk postmenopausal women, according to randomized trial results.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on June 4, 2011 at 4:32 pm By:

MedicalNews Medical News Health News

ASCO: Exemestane Scores for Primary Prevention of Breast CA (CME/CE) http://bit.ly/mecJgV

12 months ago...

Medical News: ASCO: Exemestane May Change Practice in Breast Ca Prevention - in Meeting Coverage, ASCO from MedPage Today

medpagetoday.com — “CHICAGO -- The aromatase inhibitor exemestane (Aromasin) stands to play a big role in primary prevention of breast cancer, leading specialists said here at the American Society of Clinical Oncology meView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on August 29, 2011 at 7:06 pm By:

Medical News: ASCO: Exemestane Scores for Primary Prevention of Breast Ca - in Meeting Coverage, ASCO from MedPage Today

medpagetoday.com — “CHICAGO -- Make room, tamoxifen: The aromatase inhibitor exemestane (Aromasin) prevents first breast cancers in moderate- to high-risk postmenopausal women, according to randomized trial results.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on August 29, 2011 at 7:09 pm By:

Medical News: ASCO: Exemestane May Change Practice in Breast Ca Prevention - in Meeting Coverage, ASCO from MedPage Today

medpagetoday.com — “CHICAGO -- The aromatase inhibitor exemestane (Aromasin) stands to play a big role in primary prevention of breast cancer, leading specialists said here at the American Society of Clinical Oncology meView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on June 6, 2011 at 9:28 pm By:

MedicalNews Medical News Health News

ASCO: Exemestane May Change Practice in Breast Ca Prevention (with video) http://bit.ly/m7fTA7

12 months ago...

Medical News: SABCS: Aromatase Inhibitor Good Upfront or in Sequence - in Meeting Coverage, SABCS from MedPage Today

medpagetoday.com — “SAN ANTONIO -- Women get the same breast cancer outcomes long term whether they start out on exemestane (Aromasin) or switch to it after a few years on tamoxifen, researchers found.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on December 12, 2009 at 11:37 pm By:

medical_tweets medical_tweets Health News

SABCS: Aromatase Inhibitor Good Upfront or in Sequence (CME/CE) SAN ANTONIO (MedPage Today) -- Women get the same bre.. http://bit.ly/67X4mr

2 years ago...

Walk 40 Miles in My Shoes --" Cancer Matters

cancer-matters.blogs.hopkinsmedicine.org — “Walk 40 Miles in My Shoes --" Cancer MattersView full resource at cancer-matters.blogs.hopkinsmedicine.org

  • View Related
  • Share

Most Recently Shared on April 30, 2011 at 3:54 pm By:

HopkinsMedNews JohnsHopkinsMedicine Health News

Pictures: Blogger and breast cancer survivor Elissa Bantug at the Avon Walk in Wash, D.C. http://bit.ly/lHUSQ3

1 year ago...

Chaparral | GreenMedInfo | Substance | Natural Medicine | Alternative Medicine

greenmedinfo.com — “GreenMedInfo contains 4 articles on Chaparral indicating that it may have therapeutic value in the treatment of Oxidative Stress, Breast Cancer, and GallstonesView full resource at greenmedinfo.com

  • View Related
  • Share

Most Recently Shared on May 4, 2011 at 11:56 am By:

sayerji Sayer Ji CAM and Health Advocate

The oldest known living organism on the planet is found in this picture. "The creosote bush, in Southern... http://fb.me/FiDDfgRi

1 year ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

  • drugscom

    Drugs.com

    Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.

    View Profile

  • Drugs_Devices

    Drugs and Devices OW

    Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.

    View Profile

  • MedicalNews

    Medical News

    unbiased curator, editor & aggregator of the latest medical and healthcare news and information

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390